Patent details

EP3009431 Title: 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER

Basic Information

Publication number:
EP3009431
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP151926581
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER
French Title of Invention:
DÉRIVÉS DE 2-(2,4,5-SUBSTITUÉ-ANILINO)PYRIMIDINE UTILISÉS COMME MODULATEURS DU RÉCEPTEUR EGFR UTILES POUR LE TRAITEMENT DU CANCER
German Title of Invention:
2-(2,4,5-SUBSTITUIERTES-ANILIN)PYRIMIDIN-DERIVATE ALS EGFR-MODULATOREN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
25/07/2012
Grant date:
25/10/2017
EP Publication Date:
20/04/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/10/2017
EP B1 Publication Date:
25/10/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/07/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2017
 
 

Name:
Astrazeneca AB
Address:
Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
21/12/2017
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
CHUAQUI, Claudio Edmundo
Address:
United States (US)

2

Name:
REDFEARN, Heather Marie
Address:
United Kingdom (GB)

3

Name:
WARD, Richard Andrew
Address:
United Kingdom (GB)

4

Name:
KADAMBAR, Vasantha Krishna
Address:
United Kingdom (GB)

5

Name:
BUTTERWORTH, Sam
Address:
United Kingdom (GB)

6

Name:
CHINTAKUNTLA, Chandrasekhara Reddy
Address:
United Kingdom (GB)

7

Name:
FINLAY, Maurice Raymond Verschoyle
Address:
United Kingdom (GB)

8

Name:
MURUGAN, Andiappan
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201161512061 P
Priority Date:
27/07/2011
Priority Country:
United States (US)

2

Priority Number:
201261591363 P
Priority Date:
27/01/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/437; A61K 31/506; A61P 35/00; C07D 401/02; C07D 471/04;

Publication

Bulletin

Bulletin Heading:
VB2
Bulletin edition number:
2021/02
Publication date:
05/01/2021
Description:
Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

European Patent Bulletin

1

Issue number:
201743
Publication date:
25/10/2017
Description:
Grant (B1)

2

Issue number:
201835
Publication date:
29/08/2018
Description:
Opposition procedure started

3

Issue number:
202007
Publication date:
12/02/2020
Description:
Opposition rejected; Patent maintained as granted

4

Issue number:
201745
Publication date:
08/11/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/06/2025
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
05/01/2018 Outgoing Correspondence 1
21/12/2017 Power Of Attorney 1